HEADER SIGNALING PROTEIN, ELECTRON TRANSPORT 17-OCT-00 1G28 TITLE STRUCTURE OF A FLAVIN-BINDING DOMAIN, LOV2, FROM THE CHIMERIC TITLE 2 PHYTOCHROME/PHOTOTROPIN PHOTORECEPTOR PHY3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHY3 PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: FMN-BINDING DOMAIN OF CHIMERIC PHYTOCHROME/PHOTOTROPIN COMPND 5 PHOTORECEPTOR, LOV3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ADIANTUM CAPILLUS-VENERIS; SOURCE 3 ORGANISM_TAXID: 13818; SOURCE 4 GENE: PHY3; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCAL-NEK KEYWDS PHOTOTROPIN, LOV, PAS FOLD, PHOTORECEPTOR, FLAVOPROTEIN, FMN-BINDING KEYWDS 2 DOMAIN, ALPHA-BETA STRUCTURE, SIGNALING PROTEIN, ELECTRON TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR S.CROSSON,K.MOFFAT REVDAT 3 07-FEB-24 1G28 1 REMARK REVDAT 2 24-FEB-09 1G28 1 VERSN REVDAT 1 21-MAR-01 1G28 0 JRNL AUTH S.CROSSON,K.MOFFAT JRNL TITL STRUCTURE OF A FLAVIN-BINDING PLANT PHOTORECEPTOR DOMAIN: JRNL TITL 2 INSIGHTS INTO LIGHT-MEDIATED SIGNAL TRANSDUCTION JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 2995 2001 JRNL REFN ISSN 0027-8424 JRNL PMID 11248020 JRNL DOI 10.1073/PNAS.051520298 REMARK 2 REMARK 2 RESOLUTION. 2.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 368490.280 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 16249 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1179 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.73 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2344 REMARK 3 BIN R VALUE (WORKING SET) : 0.4250 REMARK 3 BIN FREE R VALUE : 0.4200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 176 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3276 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 51 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.96000 REMARK 3 B22 (A**2) : -1.36000 REMARK 3 B33 (A**2) : -5.59000 REMARK 3 B12 (A**2) : 16.18000 REMARK 3 B13 (A**2) : -0.06000 REMARK 3 B23 (A**2) : 5.16000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.93 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.92 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.670 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 51.79 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1G28 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-OCT-00. REMARK 100 THE DEPOSITION ID IS D_1000012142. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CU-K-ALPHA REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16249 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.730 REMARK 200 RESOLUTION RANGE LOW (A) : 35.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.44300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 5000 MME, TRIS, GLYCEROL, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 937 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 949 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 972 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 977 CG CD CE NZ REMARK 470 GLN A 980 CG CD OE1 NE2 REMARK 470 LYS A 987 CG CD CE NZ REMARK 470 GLU A 988 CG CD OE1 OE2 REMARK 470 GLN A1023 CG CD OE1 NE2 REMARK 470 ARG B 937 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 949 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 972 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 977 CG CD CE NZ REMARK 470 GLN B 980 CG CD OE1 NE2 REMARK 470 LYS B 987 CG CD CE NZ REMARK 470 GLU B 988 CG CD OE1 OE2 REMARK 470 GLN B1023 CG CD OE1 NE2 REMARK 470 ARG C 937 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 949 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 972 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 977 CG CD CE NZ REMARK 470 GLN C 980 CG CD OE1 NE2 REMARK 470 LYS C 987 CG CD CE NZ REMARK 470 GLU C 988 CG CD OE1 OE2 REMARK 470 GLN C1023 CG CD OE1 NE2 REMARK 470 ARG D 937 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 949 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 972 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 977 CG CD CE NZ REMARK 470 GLN D 980 CG CD OE1 NE2 REMARK 470 LYS D 987 CG CD CE NZ REMARK 470 GLU D 988 CG CD OE1 OE2 REMARK 470 GLN D1023 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1016 20.92 -77.00 REMARK 500 ASP A1017 96.32 -46.78 REMARK 500 GLU A1018 -128.02 -178.21 REMARK 500 ASN A1019 57.08 -164.13 REMARK 500 ARG B1016 21.14 -75.66 REMARK 500 ASP B1017 96.94 -47.21 REMARK 500 GLU B1018 -128.00 -178.71 REMARK 500 ASN B1019 57.58 -163.85 REMARK 500 ARG C1016 21.45 -76.78 REMARK 500 ASP C1017 96.63 -47.46 REMARK 500 GLU C1018 -128.27 -178.66 REMARK 500 ASN C1019 57.17 -163.46 REMARK 500 ARG D1016 21.43 -77.00 REMARK 500 ASP D1017 96.50 -47.47 REMARK 500 GLU D1018 -128.23 -178.12 REMARK 500 ASN D1019 56.75 -163.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 1033 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 2033 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN C 3033 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN D 4033 DBREF 1G28 A 929 1032 UNP Q9ZWQ6 Q9ZWQ6_ADICA 929 1032 DBREF 1G28 B 929 1032 UNP Q9ZWQ6 Q9ZWQ6_ADICA 929 1032 DBREF 1G28 C 929 1032 UNP Q9ZWQ6 Q9ZWQ6_ADICA 929 1032 DBREF 1G28 D 929 1032 UNP Q9ZWQ6 Q9ZWQ6_ADICA 929 1032 SEQRES 1 A 104 LYS SER PHE VAL ILE THR ASP PRO ARG LEU PRO ASP ASN SEQRES 2 A 104 PRO ILE ILE PHE ALA SER ASP ARG PHE LEU GLU LEU THR SEQRES 3 A 104 GLU TYR THR ARG GLU GLU VAL LEU GLY ASN ASN CYS ARG SEQRES 4 A 104 PHE LEU GLN GLY ARG GLY THR ASP ARG LYS ALA VAL GLN SEQRES 5 A 104 LEU ILE ARG ASP ALA VAL LYS GLU GLN ARG ASP VAL THR SEQRES 6 A 104 VAL GLN VAL LEU ASN TYR THR LYS GLY GLY ARG ALA PHE SEQRES 7 A 104 TRP ASN LEU PHE HIS LEU GLN VAL MET ARG ASP GLU ASN SEQRES 8 A 104 GLY ASP VAL GLN TYR PHE ILE GLY VAL GLN GLN GLU MET SEQRES 1 B 104 LYS SER PHE VAL ILE THR ASP PRO ARG LEU PRO ASP ASN SEQRES 2 B 104 PRO ILE ILE PHE ALA SER ASP ARG PHE LEU GLU LEU THR SEQRES 3 B 104 GLU TYR THR ARG GLU GLU VAL LEU GLY ASN ASN CYS ARG SEQRES 4 B 104 PHE LEU GLN GLY ARG GLY THR ASP ARG LYS ALA VAL GLN SEQRES 5 B 104 LEU ILE ARG ASP ALA VAL LYS GLU GLN ARG ASP VAL THR SEQRES 6 B 104 VAL GLN VAL LEU ASN TYR THR LYS GLY GLY ARG ALA PHE SEQRES 7 B 104 TRP ASN LEU PHE HIS LEU GLN VAL MET ARG ASP GLU ASN SEQRES 8 B 104 GLY ASP VAL GLN TYR PHE ILE GLY VAL GLN GLN GLU MET SEQRES 1 C 104 LYS SER PHE VAL ILE THR ASP PRO ARG LEU PRO ASP ASN SEQRES 2 C 104 PRO ILE ILE PHE ALA SER ASP ARG PHE LEU GLU LEU THR SEQRES 3 C 104 GLU TYR THR ARG GLU GLU VAL LEU GLY ASN ASN CYS ARG SEQRES 4 C 104 PHE LEU GLN GLY ARG GLY THR ASP ARG LYS ALA VAL GLN SEQRES 5 C 104 LEU ILE ARG ASP ALA VAL LYS GLU GLN ARG ASP VAL THR SEQRES 6 C 104 VAL GLN VAL LEU ASN TYR THR LYS GLY GLY ARG ALA PHE SEQRES 7 C 104 TRP ASN LEU PHE HIS LEU GLN VAL MET ARG ASP GLU ASN SEQRES 8 C 104 GLY ASP VAL GLN TYR PHE ILE GLY VAL GLN GLN GLU MET SEQRES 1 D 104 LYS SER PHE VAL ILE THR ASP PRO ARG LEU PRO ASP ASN SEQRES 2 D 104 PRO ILE ILE PHE ALA SER ASP ARG PHE LEU GLU LEU THR SEQRES 3 D 104 GLU TYR THR ARG GLU GLU VAL LEU GLY ASN ASN CYS ARG SEQRES 4 D 104 PHE LEU GLN GLY ARG GLY THR ASP ARG LYS ALA VAL GLN SEQRES 5 D 104 LEU ILE ARG ASP ALA VAL LYS GLU GLN ARG ASP VAL THR SEQRES 6 D 104 VAL GLN VAL LEU ASN TYR THR LYS GLY GLY ARG ALA PHE SEQRES 7 D 104 TRP ASN LEU PHE HIS LEU GLN VAL MET ARG ASP GLU ASN SEQRES 8 D 104 GLY ASP VAL GLN TYR PHE ILE GLY VAL GLN GLN GLU MET HET FMN A1033 31 HET FMN B2033 31 HET FMN C3033 31 HET FMN D4033 31 HETNAM FMN FLAVIN MONONUCLEOTIDE HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 5 FMN 4(C17 H21 N4 O9 P) FORMUL 9 HOH *51(H2 O) HELIX 1 1 SER A 947 GLU A 955 1 9 HELIX 2 2 THR A 957 LEU A 962 1 6 HELIX 3 3 ASN A 965 LEU A 969 5 5 HELIX 4 4 ASP A 975 GLN A 989 1 15 HELIX 5 5 SER B 947 GLU B 955 1 9 HELIX 6 6 THR B 957 LEU B 962 1 6 HELIX 7 7 ASN B 965 LEU B 969 5 5 HELIX 8 8 ASP B 975 GLN B 989 1 15 HELIX 9 9 SER C 947 GLU C 955 1 9 HELIX 10 10 THR C 957 LEU C 962 1 6 HELIX 11 11 ASN C 965 LEU C 969 5 5 HELIX 12 12 ASP C 975 GLN C 989 1 15 HELIX 13 13 SER D 947 GLU D 955 1 9 HELIX 14 14 THR D 957 LEU D 962 1 6 HELIX 15 15 ASN D 965 LEU D 969 5 5 HELIX 16 16 ASP D 975 GLN D 989 1 15 SHEET 1 A 5 ILE A 943 ALA A 946 0 SHEET 2 A 5 SER A 930 THR A 934 -1 O ILE A 933 N ILE A 944 SHEET 3 A 5 TYR A1024 GLU A1031 -1 O PHE A1025 N THR A 934 SHEET 4 A 5 ALA A1005 MET A1015 -1 N LEU A1009 O GLN A1030 SHEET 5 A 5 VAL A 992 TYR A 999 -1 O VAL A 992 N LEU A1012 SHEET 1 B 5 ILE B 943 ALA B 946 0 SHEET 2 B 5 SER B 930 THR B 934 -1 O ILE B 933 N ILE B 944 SHEET 3 B 5 TYR B1024 GLU B1031 -1 O PHE B1025 N THR B 934 SHEET 4 B 5 ALA B1005 MET B1015 -1 N LEU B1009 O GLN B1030 SHEET 5 B 5 VAL B 992 TYR B 999 -1 O VAL B 992 N LEU B1012 SHEET 1 C 5 ILE C 943 ALA C 946 0 SHEET 2 C 5 SER C 930 THR C 934 -1 O ILE C 933 N ILE C 944 SHEET 3 C 5 TYR C1024 GLU C1031 -1 O PHE C1025 N THR C 934 SHEET 4 C 5 ALA C1005 MET C1015 -1 N LEU C1009 O GLN C1030 SHEET 5 C 5 VAL C 992 TYR C 999 -1 O VAL C 992 N LEU C1012 SHEET 1 D 5 ILE D 943 ALA D 946 0 SHEET 2 D 5 SER D 930 THR D 934 -1 O ILE D 933 N ILE D 944 SHEET 3 D 5 TYR D1024 GLU D1031 -1 O PHE D1025 N THR D 934 SHEET 4 D 5 ALA D1005 MET D1015 -1 N LEU D1009 O GLN D1030 SHEET 5 D 5 VAL D 992 TYR D 999 -1 O VAL D 992 N LEU D1012 SITE 1 AC1 18 HOH A 34 HOH A 46 THR A 934 ASN A 941 SITE 2 AC1 18 ASN A 965 CYS A 966 ARG A 967 LEU A 969 SITE 3 AC1 18 GLN A 970 VAL A 979 ILE A 982 ARG A 983 SITE 4 AC1 18 ASN A 998 ASN A1008 PHE A1010 PHE A1025 SITE 5 AC1 18 GLY A1027 GLN A1029 SITE 1 AC2 17 HOH B 51 THR B 934 ASN B 941 ASN B 965 SITE 2 AC2 17 CYS B 966 ARG B 967 LEU B 969 GLN B 970 SITE 3 AC2 17 VAL B 979 ILE B 982 ARG B 983 ASN B 998 SITE 4 AC2 17 ASN B1008 PHE B1010 PHE B1025 GLY B1027 SITE 5 AC2 17 GLN B1029 SITE 1 AC3 17 HOH C 25 THR C 934 ASN C 941 ASN C 965 SITE 2 AC3 17 CYS C 966 ARG C 967 LEU C 969 GLN C 970 SITE 3 AC3 17 VAL C 979 ILE C 982 ARG C 983 ASN C 998 SITE 4 AC3 17 ASN C1008 PHE C1010 PHE C1025 GLY C1027 SITE 5 AC3 17 GLN C1029 SITE 1 AC4 18 HOH D 3 HOH D 49 THR D 934 ASN D 941 SITE 2 AC4 18 ASN D 965 CYS D 966 ARG D 967 LEU D 969 SITE 3 AC4 18 GLN D 970 VAL D 979 ILE D 982 ARG D 983 SITE 4 AC4 18 ASN D 998 ASN D1008 PHE D1010 PHE D1025 SITE 5 AC4 18 GLY D1027 GLN D1029 CRYST1 44.890 54.078 70.619 93.32 94.01 90.06 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022277 0.000023 0.001566 0.00000 SCALE2 0.000000 0.018492 0.001077 0.00000 SCALE3 0.000000 0.000000 0.014219 0.00000